{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:07:56Z","timestamp":1781276876879,"version":"3.54.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic neuropathy (DN) is one of the most common and debilitating complications of diabetes mellitus, yet its precise pathogenesis remains incomplete. Emerging evidence highlights the gut microbiome as a key factor linking metabolic dysfunction, immune activation, and neuronal damage. Even minor dysbiosis may interfere with microbial metabolite balance and disrupt intestinal integrity, leading to local and, consequently, systemic inflammation, which in turn drives altered pain response via the gut-brain-immune axis. Recent clinical and preclinical data show that reduced short-chain fatty acid availability, altered bile acid and tryptophan metabolism, let alone expansion of pro-inflammatory species collaboratively contribute to DN onset and progression. Moreover, advances in metagenomics and metabolomics reveal reproducible microbiome-derived biomarkers that could predict neuropathy risk and pain phenotypes independent of glycemic control, supporting the microbiome as both a mechanistic driver and a measurable potential diagnostic tool. In the context of management, microbiota-affected interventions, such as probiotics, synbiotics, omega-3 supplementation, and fecal microbiota transplantation, show early promise in alleviating symptoms and improving nerve function. This mini-review synthesizes current evidence on the microbiome\u2019s role in DN, emphasizing its dual potential as a biomarker for early diagnosis and a therapeutic target for precision microbiome-based interventions.<\/jats:p>","DOI":"10.3389\/fendo.2025.1710868","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:22:04Z","timestamp":1762147324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating gut microbiota into multidisciplinary perspectives on diabetic neuropathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Maksym","family":"Horiachok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Potapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taras","family":"Ivanykovych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Yerokhovych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeva","family":"Ilkiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"B1","volume-title":"Diabetic neuropathy","author":"Vinik","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: A position statement by the American diabetes association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2008.00555.x","article-title":"Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: The MONICA\/KORA Augsburg surveys S2 and S3","volume":"10","author":"Ziegler","year":"2009","journal-title":"Pain Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1582","article-title":"Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: A population-representative study from Scotland","volume":"43","author":"Jeyam","year":"2020","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1583","article-title":"The contemporary prevalence of diabetic neuropathy in type 1 diabetes: Findings from the T1D exchange","volume":"43","author":"Mizokami-Stout","year":"2020","journal-title":"Diabetes Care"},{"key":"B6","volume-title":"Prediabetes: A high-risk state for diabetes development","author":"Tab\u00e1k","year":"2012"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050586","article-title":"Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study","volume":"39","author":"Tesfaye","year":"1996","journal-title":"Diabetologia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.2.S54","article-title":"Classification, differential diagnosis, and staging of diabetic peripheral neuropathy","volume":"46","author":"Thomas","year":"1997","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0046-9","article-title":"Gut-microbiome-related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial","volume":"42","author":"Heianza","year":"2018","journal-title":"Int J Obes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"300060520936806","DOI":"10.1177\/0300060520936806","article-title":"Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2023.05.003","article-title":"New perspectives in diabetic neuropathy","volume":"111","author":"Eid","year":"2023","journal-title":"Neuron"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: A meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Sci (1979)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318320","article-title":"Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time","volume":"69","author":"de Groot","year":"2019","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00581-2","article-title":"Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders","volume":"19","author":"Metwaly","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i21.2320","article-title":"Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome","volume":"28","author":"Tang","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0511","article-title":"Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis","volume":"161","author":"Griebeler","year":"2014","journal-title":"Ann Internal Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.31612\/2616-4868.2.2025.06","article-title":"Exploring the role of gut microbiota in patients with multiple sclerosis in Ukraine: A cross-sectional study","volume":"2","author":"Potapova","year":"2025","journal-title":"Clin Prev Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113846","article-title":"The link between gut microbiota and diabetic peripheral neuropathy: a new perspective for treatment","volume":"153","author":"Zhao","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2024.04.019","article-title":"Causal relationships between gut microbiota, gut metabolites, and diabetic neuropathy: A Mendelian randomization study","volume":"62","author":"Tang","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1388927","article-title":"Causal effects of gut microbiota on diabetic neuropathy: A two-sample Mendelian randomization study","volume":"15","author":"Xu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01514-y","article-title":"Genetically predicted immune cells mediate the association between gut microbiota and neuropathy pain","volume":"32","author":"Lan","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"150374","DOI":"10.1016\/j.bbrc.2024.150374","article-title":"Antidepressant effect of carvedilol on streptozotocin-induced diabetic peripheral neuropathy mice by altering gut microbiota","volume":"730","author":"Wu","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1402014","article-title":"The causal relationship between gut microbiota and diabetic neuropathy: a bi-directional two-sample Mendelian randomization study","volume":"15","author":"Xie","year":"2024","journal-title":"Front Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1364280","article-title":"Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1419160","article-title":"The potential mechanism of action of gut flora and bile acids through the TGR5\/TRPV1 signaling pathway in diabetic peripheral neuropathic pain","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"39(1)","DOI":"10.1096\/fj.202401478RR","article-title":"Novel insights into the role of gut microbiota and its metabolites in diabetic chronic wounds","author":"Huang","year":"2025","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-025-03352-3","article-title":"Probiotics alleviate painful diabetic neuropathy by modulating the microbiota\u2013gut\u2013nerve axis in rats","volume":"22","author":"Jiang","year":"2025","journal-title":"J Neuroinflamm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01447-x","article-title":"Diabetic neuropathy: understanding the nexus of diabetic neuropathy, gut dysbiosis and cognitive impairment","volume":"23","author":"Babu","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12866-025-04015-2","article-title":"Changes of intestinal microbiome and its relationship with painful diabetic neuropathy in rats","volume":"25","author":"Jia","year":"2025","journal-title":"BMC Microbiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S428933","article-title":"Formate might be a novel potential serum metabolic biomarker for type 2 diabetic peripheral neuropathy","volume":"16","author":"Xu","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998280396231212114345","article-title":"Association between gut microbiota compositions with microvascular complications in individuals with diabetes: A systematic review","volume":"20","author":"Hasani","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41387-024-00328-9","article-title":"Diabetic foot exacerbates gut mycobiome dysbiosis in adult patients with type 2 diabetes mellitus: revealing diagnostic markers","volume":"14","author":"Cai","year":"2024","journal-title":"Nutr Diabetes"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24279","article-title":"Evidence of differential microbiomes in healing versus non-healing diabetic foot ulcers prior to and following foot salvage therapy","volume":"37","author":"MacDonald","year":"2019","journal-title":"J Orthopaedic Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01587-5","article-title":"Bacterial diversity and inflammatory response at first-time visit in younger and older individuals with diabetic foot infection (DFI)","volume":"58","author":"D\u00f6rr","year":"2021","journal-title":"Acta Diabetol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110991","article-title":"An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14203","article-title":"Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy","volume":"15","author":"Niimi","year":"2024","journal-title":"J Diabetes Investig"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02640-2","article-title":"Integrated analysis of gut microbiota, fecal and serum metabolites in type 2 diabetes mellitus with peripheral neuropathy","volume":"48","author":"Xu","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-025-03352-3","article-title":"Probiotics alleviate painful diabetic neuropathy by modulating the microbiota-gut-nerve axis in rats","volume":"22","author":"Jiang","year":"2025","journal-title":"J Neuroinflam"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.21926\/obm.neurobiol.2403247","article-title":"A probiotic mixture decreases neuropathy and oxidative stress markers in diabetic rats","volume":"8","author":"Shabani","year":"2024","journal-title":"OBM Neurobiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.06.010","article-title":"Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes","volume":"35","author":"Yang","year":"2023","journal-title":". Cell Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"10.1002\/dmrr.2970","DOI":"10.1002\/dmrr.2970","article-title":"The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial","volume":"34","author":"Mohseni","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.02.016","article-title":"The effect of probiotic and synbiotic supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: A systematic review and meta-analysis of randomized controlled trials","volume":"142","author":"Zheng","year":"2019","journal-title":"Pharmacol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.08.009","article-title":"Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Sabico","year":"2019","journal-title":"Clin Nutr"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004033","article-title":"Effect of omega-3 supplementation on neuropathy in type 1 diabetes","volume":"88","author":"Lewis","year":"2017","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217357","article-title":"Lactobacillus rhamnosus TR08 improves dyslipidemia in mice fed with a high fat diet by regulating the intestinal microbiota, reducing systemic inflammatory response, and promoting sphingomholipid metabolism","volume":"27","author":"Feng","year":"202","journal-title":"Molecules"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2174\/1573399820666230522121707","article-title":"Technological trends involving probiotics in the treatment of diabetic neuropathy: A patent review (2009-2022)","volume":"20","author":"Silva Santos","year":"2023","journal-title":"Curr Diabetes Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1710868\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:22:05Z","timestamp":1762147325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1710868\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":48,"alternative-id":["10.3389\/fendo.2025.1710868"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1710868","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"article-number":"1710868"}}